New drug EB070 takes first step: safety check in healthy volunteers
NCT ID NCT07413536
First seen Feb 17, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This early-stage study tests whether a new drug, EB070, is safe and how the body processes it. About 36 healthy adults will receive a single injection of either the drug or a placebo. Researchers will monitor side effects and measure drug levels in the blood over several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.